Crowdonomics
All companies
Timeplast logo

Timeplast

Operating

Timeplast, Inc.

Industrial & Manufacturing · Engineering · Longwood, FL · Founded 2021

Techno-organic material with the potential to fully disintegrate in water within hours

Post-money valuation ⓘ
$45.0M
As of Jul 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$9,917,289
Across 2 rounds since 2022
Latest share price
$1.89
Reg CF · Common Stock · Sep 2024 offering price

Financials

FY2020–FY2024 · from SEC filings · hover any figure for its source
$0
−$289K
2020
$12K
−$295K
2021
$61K
−$395K
2022
$37K
−$1.5M
2023
$49K
−$1.4M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 audited*
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$11,739
$61,424
$37,181
$48,529
Cost of goods sold
$0
$1,995
$16,575
$44,186
$29,306
Gross margin
—
83%
73%
-19%
40%
Net income
-$288,696
-$294,547
-$394,679
-$1,547,318
-$1,414,186
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$257,849
$5,013
$318,503
$1,987,618
$67,867
Accounts receivable
$0
$0
$0
$3,210
$20,865
Total assets
$257,849
$5,013
$362,094
$2,118,113
$405,988
Short-term debt
$530,000
$571,710
$633,726
$709,092
$45,509
Long-term debt
$0
$0
$0
$0
$0
Total liabilities
$530,000
$571,710
$633,726
$709,092
$45,509
Other
Headcount
—
6
6
10
7

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$40.0M
pre-money
$85.7M
est. pre-money
Reg CF · Common · Jun 2022
Reg CF · Common · Sep 2024

Blue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Share price over rounds

$1.89$0.945$1.00
Jun 2022Sep 2024
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Dec 31, 2023
ClassOutstandingVotes / shareShare of totalLast price
Common Stock45,356,622—100.0%$1.89Sep 2024

Shares outstanding over timein today's share terms

45M23M0
Dec 2022Dec 2023
Common Stock

Principal holders% as the filing states it, Jun 17, 2022

  • Owned Common Manuel Rendon11,540,000 shares28.9%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $5M / $5MInvestors 2,758Est. pre-money $85.7M
Raised $4.9M / $5MInvestors 5,965Post-money $45M

Team

6 people
Manuel RendonFounder
Founder, Inventor and CEO

Manuel is a former PepsiCo executive and Environmental Engineer who created and patented a bio-based hydro soluble plastic with limited water resistance and a liquid solution for the molecular disintegration and up-cycling of fossil-based plastics. He founded Timeplast with the intention of bringing to market innovative and realistic approaches to address the Plastic Pollution issue.

Dan Younkman
Growth Advisor

Dan is an expert in corporate growth consulting and specialty retailing.

Henry Aular
European Operations Manager

Henry graduated as an Electrical Engineer at Ohio University in December 1980. Since January 2018, he has been working at Simoparma Packaging in Italy.

Jose Rodriguez
Latin American Sales Manager

Jose is a professional formed at 3M Company, working there for about fourteen years in Venezuela. He has now been working in Mexico for eight years with technical sales on the electrical market, and at the same time, working together with Manuel and the Timeplast team looking for opportunities for Timeplast in the Mexican and broader Latin American market.

Tony Martinez
Global Operations Manager

Operations Management professional with over 20 years of experience in B2B sector ranging from startups to Fortune 500 companies.

Victor Cardenal
Global Sales Manager

Victor has over 20 years of experience in upper managing sales for multinational companies.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 3 of 4 annual reports (FY2022–FY2025)

5,965 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-UAug 7, 20260002070024-26-000033
    EDGAR
  • Form C/AJul 3, 20250002070024-25-000001
    EDGAR
  • Form C-ARApr 29, 20250001644600-25-000029
    EDGAR
  • Form C/AApr 29, 20250001644600-25-000027
    EDGAR
  • Form C/AApr 25, 20250001644600-25-000025
    EDGAR
  • Form C/ASep 27, 20240001644600-24-000090
    EDGAR
  • Form C-USep 27, 20240001644600-24-000089
    EDGAR
  • Form CSep 4, 20240001644600-24-000078
    EDGAR
Source: ManualCIK 0001933967FLShare price $1.89

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.